[Lichen sclerosus--clinical and therapeutic aspects]

Akush Ginekol (Sofiia). 2014;53(1):35-9.
[Article in Bulgarian]

Abstract

Lichen sclerosus (LS) is a lymphocyte-mediated inflammatory dermatosis with a characteristic location (85-98%) in the anogenital region. The authors point out the main features in the epidemiology and clinical presentation of the disease and the possible approach to neoplastic development. Expanded differential diagnosis of LS sparked not only dermatologists but also gynecologists, urologists and GPs. Points are the chronic course of the disease and resistance to therapy. Discuss the results of the treatment of LS with less potent topical corticosteroids, calcineurin inhibitors, phototherapy and photodynamic therapy, surgery.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Calcineurin Inhibitors
  • Humans
  • Lichen Sclerosus et Atrophicus / epidemiology
  • Lichen Sclerosus et Atrophicus / immunology
  • Lichen Sclerosus et Atrophicus / pathology*
  • Lichen Sclerosus et Atrophicus / therapy*
  • Phototherapy / methods
  • Skin / drug effects
  • Skin / immunology
  • Skin / pathology

Substances

  • Adrenal Cortex Hormones
  • Calcineurin Inhibitors